Tag: Weight Loss
GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
Increased risks seen for pancreatitis, bowel obstruction, and gastroparesis, but not for biliary disease
Durable Reductions in HbA1c, Body Weight Seen With Semaglutide
Real-world study shows greater reductions in HbA1c and body weight for patients with proportion of days covered ≥60 percent
Minimally Processed Red Meat Can Work in Weight Loss Diet With Diabetes
High-protein, lean beef diet achieved similar weight loss, glucose control as normal-protein diet with no red meat
Women’s Weight Loss Tied to Lower Odds of Living to 90 Years or Older
Three-year weight loss in older women tied to 33 percent lower odds of reaching age 90 years; association stronger for unintentional versus intentional weight loss
Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
Based on body mass index, 120 million Americans would qualify to take Wegovy
Odds of Clinically Meaningful Weight Loss Low in Adults With Overweight, Obesity
Despite fewer than one in 10 achieving it, likelihood of ≥5 percent weight loss was higher than reaching healthy weight body mass index category
Wegovy Lowered Users’ Heart Risks in New Trial
Clinical trial demonstrates reduction in major adverse cardiovascular events of 20 percent, drug maker says
Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
Lawsuit alleges drugmakers failed to adequately warn patients about the risk for severe stomach problems
Time-Restricted Eating May Aid Weight Loss With Type 2 Diabetes
No change in cardiometabolic risk factors or glycemic control seen over six months
European Regulators Investigating Risk for Suicidal Thoughts With Popular Weight-Loss Drugs
Three case reports from Iceland spurred the review; two of the cases involved Ozempic